Healthcare's 2026 Renaissance: Why Wall Street's Top Strategists Are Betting on Pharma and Biotech
After years of underperformance, healthcare stocks are poised for a breakout in 2026. Here's why Citi, JPMorgan, and other major banks are overweight on the sector.